A Knowledge Transfer seminar is being held to explore the promise of regenerative medicine and AI.
The speaker is Peter Egelberg, Founder and CEO of Phase Holographic Imaging (PHI). PHI leads the ground-breaking development of time-lapse cytometry instrumentation and software.
Treatments based on laboratory cultured cells are today curing cancer patients. Besides cancer, cell-based therapies have the potential to heal and rejuvenate patients suffering from diseases like Parkinson’s, Alzheimer’s, diabetes and heart disease. For decades scientists have been exploring stem cells and artificial neural networks. Jointly, these seemingly unrelated technologies are now on the verge of transforming healthcare as we know it.
Digital technologies developed at CERN for high-energy physics might have promise in this field and are worth investigating.
Come along and find out more about this fascinating topic.
This seminar will take place in person and on zoom, more information is available on the event page: https://indico.cern.ch/e/regenmed.